Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers [PDF]
World Allergy Organization Journal, 2023 Background: Bradykinin angioedemas are a potentially serious side effect of angiotensin-converting enzyme inhibitors (ACEI) and more controversially of angiotensin II receptor blockers (ARB).
Aurélie Du-Thanh
exaly +4 more sources
The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency [PDF]
Clinical and Translational Allergy, 2021 Background Angioedemas localized in the upper airway are potentially life threatening, and without proper treatment, they may lead to death by suffocation. Upper airway edemas (UAE) in bradykinin‐mediated angioedemas can even be the first symptoms of the
Zsuzsanna Balla +2 more
exaly +3 more sources
Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports [PDF]
PLoS ONE, 2020 IntroductionAngioedema is a subcutaneous swelling typically affecting the face, larynx or pharynx. It is a known adverse drug reaction (ADR) of ACE inhibitors (ACEi), angiotensin-II-receptor blockers (ARBs) and aliskiren (renin inhibitor).
Diana Dubrall +2 more
exaly +3 more sources
A case of angioedema of hereditary origin in a rural clinic near Subotica [PDF]
ABC: časopis urgentne medicine, 2023 Introduction: Hereditary angioedema (HAE) is inherited in an autosomal dominant manner. It manifests with bradykinin-mediated swelling due to a deficiency of C1 inhibitor.
Gavrilović Nikola +2 more
doaj +3 more sources
Prevalence of autoantibodies in a group of hereditary angioedema patients Prevalência de autoanticorpos em uma população com angioedema hereditário [PDF]
Anais Brasileiros de Dermatologia, 2012 Hereditary Angioedema is a dominantly inherited disease. Routine screening of autoantibodies (AAB) is not recommended for individuals with Hereditary Angioedema; however, prevalence of these antibodies in Hereditary Angioedema patients is not well ...
Sergio Duarte Dortas Junior +7 more
doaj +2 more sources
Hereditary angioedema type III (estrogen-dependent) report of three cases and literature review* [PDF]
Anais Brasileiros de Dermatologia, 2013 In this article, three cases of hereditary angioedema (HAE) type III (estrogen-dependent or with normal C1 inhibitor) are reported. The HAE was initially described in women of the same family in association with high-leveled estrogenic conditions such as
Amanda Rodrigues Miranda +5 more
doaj +2 more sources
Reply to “A Case Report about the Management of Hereditary Angioedema with Normal Complement Levels during Pregnancy” [PDF]
Acta Médica PortuguesaN/A.
Ana Luísa Moura +2 more
doaj +3 more sources
Hereditary angioedema prevalence and satisfaction with prophylaxis in South Australia [PDF]
World Allergy Organization JournalBackground: Hereditary angioedema (HAE) due to deficiency of C1 Inhibitor (C1INH-HAE) is a rare, unpredictable and potentially fatal genetic disorder. There are relatively few systematic population prevalence studies, with reports from various countries ...
Alexander Troelnikov, MBBS +4 more
doaj +2 more sources
Complex analysis of the national Hereditary angioedema cohort in Slovakia – Identification of 12 novel variants in SERPING1 gene [PDF]
World Allergy Organization JournalBackground: Hereditary angioedema (HAE) is a rare autosomal dominant genetic disease characterised by acute episodes of non-pruritic skin and submucosal swelling caused by increase in vascular permeability.
Adam Markocsy, MD +11 more
doaj +2 more sources
Long-term prophylaxis of hereditary angioedema [PDF]
Liječnički vjesnik, 2022 Hereditary angioedema (HAE) is a rare inherited disease characterized by recurrent attacks of painful swelling of the subcutaneous and submucosal tissues.
Dijana Perković +8 more
doaj +1 more source